Skip to main content

Alzheimer's Disease, Dementia & Cognitive Disorders

The US Food and Drug Administration (FDA) has approved Tauvid (flortaucipir F18) for intravenous injection in adults with cognitive impairment who are being evaluated for Alzheimer’s disease.
Virtual reality technology may one day replace traditional pencil-and-paper activities for cognitive training in older adults, suggests a study published online in the International Journal of Geriatric Psychiatry.
Stress-related disorders, such as post-traumatic stress disorder, are associated with a considerably higher risk of developing neurodegenerative diseases, according to a study published online in JAMA Neurology. 
Low-cost, noninvasive cognitive testing may help identify people at risk of progressing to the first stage of Alzheimer’s disease, according to a study published online in Biological Psychiatry.
Consuming more food and drink with the antioxidant flavonol is associated with a smaller chance of developing Alzheimer’s dementia years later, researchers reported in Neurology.
Back to Top